HomeEGTX • STO
add
Egetis Therapeutics AB (publ)
Previous close
kr 5.90
Day range
kr 5.83 - kr 6.10
Year range
kr 4.04 - kr 9.30
Market cap
2.12B SEK
Avg Volume
896.63K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 9.40M | -22.95% |
Operating expense | 86.70M | -9.78% |
Net income | -86.20M | 0.00% |
Net profit margin | -917.02 | -29.79% |
Earnings per share | -0.30 | 0.00% |
EBITDA | -80.10M | 6.53% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 129.90M | 52.82% |
Total assets | 577.50M | 8.13% |
Total liabilities | 258.90M | 285.27% |
Total equity | 318.60M | — |
Shares outstanding | 292.57M | — |
Price to book | 5.41 | — |
Return on assets | -33.09% | — |
Return on capital | -42.96% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -86.20M | 0.00% |
Cash from operations | -62.50M | 32.87% |
Cash from investing | — | — |
Cash from financing | -600.00K | 0.00% |
Net change in cash | -62.70M | 33.44% |
Free cash flow | -41.16M | 36.03% |
About
Founded
2006
Website
Employees
39
